Nexpoint Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,950
Closed -$439K 167
2021
Q4
$439K Buy
+1,950
New +$412K 0.06% 141
2020
Q4
Sell
-10,000
Closed -$2.54M 146
2020
Q3
$2.54M Buy
+10,000
New +$2.48M 0.58% 31
2020
Q1
Sell
-3,030
Closed -$730K 218
2019
Q4
$730K Buy
+3,030
New +$668K 0.06% 162

Other funds holding AMGN

Nexpoint Asset Management's AMGN Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 1,950 shares — an estimated $439K sold.

Nexpoint Asset Management first reported a position in AMGN in Q4 2019 and held it in 3 quarters. The position peaked at $2.54M in Q3 2020. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Nexpoint Asset Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 1,950 Amgen shares in Q1 2022, an estimated $439K.
  • Nexpoint Asset Management first reported a position in Amgen in Q4 2019 and held it in 3 quarters.
  • Nexpoint Asset Management's Amgen position peaked at $2.54M in Q3 2020.
  • 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.